NCT05727969

Brief Summary

This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart rate. SPI value is correlated to pain and ranges from 0 to 100, higher values indicate strong surgical stimulus. Its value is obtained from photoplethysmographic amplitude (PPGA) and heart rate (HR) data from pulse oximetry measurement. Prediction of the severity of postoperative pain using SPI in both adults and children has been reported by several studies. So, the authors hypothesize that dexmedetomidine infusion without giving a bolus dose may affect the SPI in pediatrics undergoing hypospadias repair.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 14, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

10 months

First QC Date

January 24, 2023

Last Update Submit

February 21, 2024

Conditions

Keywords

DexmedetomidineHypospadiasPostoperative analgesiaSurgical pleth index

Outcome Measures

Primary Outcomes (1)

  • Surgical pleth index number

    from 0 to 100, higher values indicate strong surgical stimulus

    1 minute at end of the operation after skin closure.

Secondary Outcomes (27)

  • Surgical pleth index number

    1 minute before induction of anesthesia.

  • Surgical pleth index number

    1 minute after insertion of endotracheal tube.

  • Surgical pleth index number

    1 minute after beginning of surgery with skin incision.

  • Surgical pleth index number

    5 minutes after recovery at post anesthesia care unit.

  • Mean arterial blood pressure

    5 minutes after recovery at post anesthesia care unit.

  • +22 more secondary outcomes

Other Outcomes (2)

  • Age

    1 hour preoperatively

  • American society of anesthesiology classification

    1 hour preoperatively

Study Arms (2)

Control group

PLACEBO COMPARATOR

The control group, lactated ringer solution will be infused.

Drug: Lactated RingerProcedure: HypospadiasDevice: Surgical pleth index

Dexmedetomidine group

EXPERIMENTAL

In the dexmedetomidine group, dexmedetomidine will be infused.

Drug: DexmedetomidineProcedure: HypospadiasDevice: Surgical pleth index

Interventions

Dexmedetomidine at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.

Also known as: Precedex
Dexmedetomidine group

Lactated ringer solution at a a rate of 0.5 μg/kg/hour will be infused with induction of anesthesia.

Also known as: Solution
Control group
HypospadiasPROCEDURE

Children who will undergone hypospadias surgery

Also known as: pediatric manuvere
Control groupDexmedetomidine group

The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.

Also known as: SPI
Control groupDexmedetomidine group

Eligibility Criteria

Age1 Year - 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 1-7years.
  • ASA physical status I-II.
  • Hypospadias surgery.

You may not qualify if:

  • Children having a history of mental retardation.
  • Developmental delay.
  • Allergic to dexmedetomedine.
  • Neuraxial anesthesia.
  • Cardiovascular disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fayoum University hospital

El Fayoum Qesm, Faiyum Governorate, 63514, Egypt

Location

Related Publications (3)

  • Huiku M, Uutela K, van Gils M, Korhonen I, Kymalainen M, Merilainen P, Paloheimo M, Rantanen M, Takala P, Viertio-Oja H, Yli-Hankala A. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007 Apr;98(4):447-55. doi: 10.1093/bja/aem004. Epub 2007 Feb 28.

    PMID: 17329347BACKGROUND
  • Hamunen K, Kontinen V, Hakala E, Talke P, Paloheimo M, Kalso E. Effect of pain on autonomic nervous system indices derived from photoplethysmography in healthy volunteers. Br J Anaesth. 2012 May;108(5):838-44. doi: 10.1093/bja/aes001. Epub 2012 Feb 26.

    PMID: 22369767BACKGROUND
  • Constant I, Sabourdin N. Monitoring depth of anesthesia: from consciousness to nociception. A window on subcortical brain activity. Paediatr Anaesth. 2015 Jan;25(1):73-82. doi: 10.1111/pan.12586. Epub 2014 Nov 20.

    PMID: 25410376BACKGROUND

MeSH Terms

Conditions

PainHypospadias

Interventions

DexmedetomidineRinger's LactateSolutions

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPenile DiseasesGenital Diseases, MaleGenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCrystalloid SolutionsIsotonic SolutionsPharmaceutical Preparations

Study Officials

  • Safaa G Megahed, MD

    Fayoum University

    STUDY DIRECTOR
  • Omar S Mahmoud, MD

    Fayoum University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The group's allocations will be only blinded to assessors, data collectors, and parents of children
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The randomization will be computer generated random number and the randomization sequence will be kept hidden in sealed opaque envelopes just opened after recruitment and admittance to the operating room.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of anesthesia

Study Record Dates

First Submitted

January 24, 2023

First Posted

February 14, 2023

Study Start

January 15, 2023

Primary Completion

November 15, 2023

Study Completion

December 15, 2023

Last Updated

February 22, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations